Product Code: GVR-2-68038-690-5
Hand-held Surgical Instruments Market Growth & Trends
The global hand-held surgical instruments market size is expected to reach USD 9.6 billion by 2030 at a 7.3% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic diseases, such as; cancer, chronic heart, neurological, orthopedic disorders is the leading factor driving the demand for hand-held surgical instruments market. According to the American Cancer Society, more than 16.9 million Americans with a history of invasive cancer were alive in January 2019.
The increasing geriatric population that is more susceptible to developing these disorders is another factor that is expected to propel market growth over the forecast period. According to the U.S. Census Bureau, there were more than 54 million adults aged 65 and older that lived in the U.S. in 2020. Increasing preference for plastic & reconstructive surgeries is another major factor driving the market growth. Increasing disposable income and the booming medical tourism sector in developing countries is also expected to boost the growth of the hand-held surgical instruments market.
The COVID-19 pandemic led to a significant downfall in overall sales of the hand-held surgical instruments market. Increasing focus on COVID-19-infected patients and postponement of elective surgeries resulted in a reduced number of surgeries being performed, which affected the market negatively. However, due to huge backlog and rise in efforts by the surgeons and healthcare facilities to generate higher revenue and fill in the demand & supply gap has helped the market to recover to great extent. Furthermore, the market represents lucrative opportunities with the world finally being able to combat and recover from the pandemic.
Hand-held Surgical Instruments Market Report Highlights
- The forceps segment held a significant market share in 2022 due to its increasing adoption in a surgical setting
- The retractors segment is projected to experience maximum growth over the forecast period due to technological advancements in this segment
- The orthopedic surgery segment held the highest market share in 2022 owing increasing incidence of musculoskeletal disorders
- The plastic and reconstructive surgery segment is expected to experience the fastest growth over the forecast period as a large number of people are opting for these procedures
- The hospitals segment held the largest revenue share in 2022 as the majority of the surgical procedures are performed in this setting
- The ambulatory surgical centers segment is expected to experience maximum growth over the forecast period owing to the growing popularity of plastic and reconstructive surgeries, ophthalmic surgeries among others in this setting
- North America held the largest share in 2022 owing to the presence of well-established healthcare infrastructure
- Asia Pacific is expected to experience the fastest growth rate during the forecast period mainly due to the presence of strong medical tourism and increasing focus on healthcare
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. End-Use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Outlook
- 2.2.2. Application Outlook
- 2.2.3. End-use Outlook
- 2.2.4. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Hand-held Surgical Instruments Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Increasing prevalence of chronic diseases
- 3.4.1.2. Increasing geriatric population
- 3.4.1.3. Rise in the number of road accidents
- 3.4.1.4. Rise in number of surgical procedures
- 3.4.2. Market restraint analysis
- 3.4.2.1. Increase in the number of minimally invasive and non-invasive procedures
- 3.4.3. Industry challenges
- 3.5. Hand-held Surgical Instruments Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.3. Major Deals & Strategic Alliances Analysis
- 3.5.4. Market Entry Strategies
Chapter 4. Hand-held Surgical Instruments Device: Product Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Forceps
- 4.1.2. Retractors
- 4.1.3. Dilators
- 4.1.4. Graspers
- 4.1.5. Scalpels
- 4.1.6. Cannulas
- 4.1.7. Dermatome
- 4.1.8. Trocars
- 4.1.9. Others
- 4.2. Product Market Share, 2022 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Hand-held Surgical Instruments Market by Product Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
- 4.5.1. Forceps
- 4.5.1.1. Market estimates and forecast 2017 - 2030 (Revenue in USD Million)
- 4.5.2. Retractors
- 4.5.2.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 4.5.3. Dilators
- 4.5.3.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 4.5.4. Graspers
- 4.5.4.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 4.5.5. Scalpels
- 4.5.5.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 4.5.6. Cannulas
- 4.5.6.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 4.5.7. Dermatomes
- 4.5.7.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 4.5.8. Trocars
- 4.5.8.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 4.5.9. Others
- 4.5.9.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
Chapter 5. Hand-held Surgical Instruments: Application Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Orthopedic Surgery
- 5.1.2. Cardiology
- 5.1.3. Ophthalmology
- 5.1.4. Wound Care
- 5.1.5. Audiology
- 5.1.6. Thoracic Surgery
- 5.1.7. Urology and Gynecology Surgery
- 5.1.8. Plastic Surgery
- 5.1.9. Neurosurgery
- 5.1.10. Others
- 5.2. Application Market Share, 2022 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Hand-held Surgical Instruments Market by Application Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
- 5.5.1. Orthopedic surgery
- 5.5.1.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.2. Cardiology
- 5.5.2.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.3. Ophthalmology
- 5.5.3.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.4. Wound care
- 5.5.4.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.5. Audiology
- 5.5.5.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.6. Thoracic surgery
- 5.5.6.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.7. Urology & Gynecology Surgery
- 5.5.7.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.8. Plastic surgery
- 5.5.8.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.9. Neurosurgery
- 5.5.9.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.10. Others
- 5.5.10.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
Chapter 6. End-Use Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Hospitals
- 6.1.2. Clinics
- 6.1.3. Ambulatory Surgical Centers
- 6.1.4. Others
- 6.2. End-Use Market Share, 2022 & 2030
- 6.3. Segment Dashboard
- 6.4. Global Hand-held Surgical Instruments Market by End-Use Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
- 6.5.1. Hospitals
- 6.5.1.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 6.5.2. Clinics
- 6.5.2.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 6.5.3. Ambulatory Surgical Centers
- 6.5.3.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 6.5.4. Others
- 6.5.4.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
Chapter 7. Hand-held Surgical Instruments Market: Regional Estimates & Trend Analysis
- 7.1. Regional market share analysis, 2022 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Regional Market Share and Leading Players, 2021
- 7.4.1. North America
- 7.4.2. Europe
- 7.4.3. Asia Pacific
- 7.4.4. Latin America
- 7.4.5. Middle East and Africa
- 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 7.5.1. North America
- 7.5.2. Europe
- 7.5.3. Asia Pacific
- 7.5.4. Latin America
- 7.5.5. Middle East and Africa
- 7.6. Market Size, & Forecasts and Trend Analysis, 2017 to 2030:
- 7.7. North America
- 7.7.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.7.2. U.S.
- 7.7.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.7.3. Canada
- 7.7.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.8. Europe
- 7.8.1. UK
- 7.8.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.8.2. Germany
- 7.8.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.8.3. France
- 7.8.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.8.4. Italy
- 7.8.4.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.8.5. Spain
- 7.8.5.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.9. Asia Pacific
- 7.9.1. Japan
- 7.9.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.9.2. China
- 7.9.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.9.3. India
- 7.9.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.10. Latin America
- 7.10.1. Brazil
- 7.10.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.10.2. Mexico
- 7.10.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.10.3. Argentina
- 7.10.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.11. MEA
- 7.11.1. South Africa
- 7.11.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.11.2. Saudi Arabia
- 7.11.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 7.11.3. UAE
- 7.11.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.2.1. Innovators
- 8.2.2. Market Leaders
- 8.2.3. Emerging Players
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2021
- 8.3.4. Zimmer Biomet Holdings
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Integra Lifesciences Corporation
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. B.Braun Melsungen AG
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Medtronic, plc.
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Smith & Nephew
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Johnson & Johnson Services, Inc.
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. BD
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Humeca BV
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. CooperSurgical Companies
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. Aspen Surgical
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. Product benchmarking
- 8.3.13.4. Strategic initiatives